The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rohrer, J. W.
Right arrow Articles by Coggin, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rohrer, J. W.
Right arrow Articles by Coggin, J. H., Jr

The Journal of Immunology, Vol 155, Issue 12 5719-5727, Copyright © 1995 by American Association of Immunologists

ARTICLES

CD8 T cell clones inhibit antitumor T cell function by secreting IL-10

JW Rohrer and JH Coggin Jr
University of South Alabama College of Medicine, Department of Microbiology and Immunology, Mobile 36688, USA.

We have reported that in irradiated, long-term surviving RFM strain of mice there is enhanced kinetics of tumor development upon challenge with RFM lymphoma cells. We reported that we cloned splenic oncofetal (OFA)-specific, noncytotoxic CD8+ T cells from such mice. These noncytotoxic CD8+ T cell clones secrete a factor upon Ag stimulation that inhibits the ability of OFA-specific RFM cytotoxic T (TC) cell clones from killing 5T RFM lymphoma cells in vitro. These supernatants do not inhibit the tumor cell-induced proliferation of the TC cell clones however. We report here that OFA-stimulated, RFM-noncytotoxic CD8 T cell clone culture supernatants also inhibit IFN-gamma-secretion by stimulated CD4 and CD8 RFM anti-OFA effector T cell clones in a dose- dependent manner. The inhibitor in those culture supernatants acts in neither an Ag-specific nor MHC-restricted manner. We find that the culture supernatants of OFA-stimulated, noncytotoxic CD8 T cell clones contain IL-10, while those from OFA-stimulated, RFM OFA-specific TC cell clones do not. We show that monoclonal anti-IL-10 Ab specifically blocks the inhibition of cytotoxic activity and IFN-gamma secretion by OFA-specific CD8 and CD4 effector T cell clones in a dose-dependent manner in vitro. Incorporation of anti-IL-10 Ab into the cytotoxicity assays of the OFA-specific, noncytotoxic CD8+ T cell clones against 5T tumor cells restores their cytotoxic activity. This may suggest that one way of inducing anergic T cells is by induction of IL-10 secretion.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
B. Friedrichs, S. Siegel, M. Kloess, A. Barsoum, J. Coggin Jr., J. Rohrer, I. Jakob, M. Tiemann, K. Heidorn, C. Schulte, et al.
Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia
J. Immunol., May 1, 2008; 180(9): 6374 - 6384.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J.-B. Lee, K.-A Lee, and J. Chang
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation
Int. Immunol., September 6, 2007; (2007) dxm072v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Elrefaei, F. L. Ventura, C. A. R. Baker, R. Clark, D. R. Bangsberg, and H. Cao
HIV-Specific IL-10-Positive CD8+ T Cells Suppress Cytolysis and IL-2 Production by CD8+ T Cells
J. Immunol., March 1, 2007; 178(5): 3265 - 3271.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-C. Yang, R. K. Batra, S. Hillinger, K. L. Reckamp, R. M. Strieter, S. M. Dubinett, and S. Sharma
Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma.
Cancer Res., March 15, 2006; 66(6): 3205 - 3213.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Rohrer, A. L. Barsoum, and J. H. Coggin Jr.
Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones.
J. Immunol., March 1, 2006; 176(5): 2844 - 2856.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Elrefaei, B. Barugahare, F. Ssali, P. Mugyenyi, and H. Cao
HIV-Specific IL-10-Positive CD8+ T Cells Are Increased in Advanced Disease and Are Associated with Decreased HIV-Specific Cytolysis
J. Immunol., January 15, 2006; 176(2): 1274 - 1280.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Sharma, S.-C. Yang, L. Zhu, K. Reckamp, B. Gardner, F. Baratelli, M. Huang, R. K. Batra, and S. M. Dubinett
Tumor Cyclooxygenase-2/Prostaglandin E2-Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
Cancer Res., June 15, 2005; 65(12): 5211 - 5220.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. S. Kang and P. M. Allen
Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses
J. Immunol., May 1, 2005; 174(9): 5382 - 5389.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Lu, J.-C. Soria, X. Tang, X.-C. Xu, L. Wang, L. Mao, R. Lotan, B. Kemp, B. N. Bekele, L. Feng, et al.
Prognostic Factors in Resected Stage I Non-Small-Cell Lung Cancer: A Multivariate Analysis of Six Molecular Markers
J. Clin. Oncol., November 15, 2004; 22(22): 4575 - 4583.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. H. Coggin Jr., J. W. Rohrer, A. L. Barsoum, and J. Vieweg
True Immunogenicity of Oncofetal Antigen/Immature Laminin Receptor Protein
Cancer Res., July 1, 2004; 64(13): 4685 - 4685.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Hillinger, S.-C. Yang, L. Zhu, M. Huang, R. Duckett, K. Atianzar, R. K. Batra, R. M. Strieter, S. M. Dubinett, and S. Sharma
EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-{gamma}-Dependent Antitumor Responses in a Lung Cancer Model
J. Immunol., December 15, 2003; 171(12): 6457 - 6465.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Siegel, A. Wagner, D. Kabelitz, M. Marget, J. Coggin Jr, A. Barsoum, J. Rohrer, N. Schmitz, and M. Zeis
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies
Blood, December 15, 2003; 102(13): 4416 - 4423.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Xie, Y. Wang, M. E. Freeman III, B. Barlogie, and Q. Yi
beta 2-Microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells
Blood, May 15, 2003; 101(10): 4005 - 4012.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-C. Soria, C. Moon, B. L. Kemp, D. D. Liu, L. Feng, X. Tang, Y.-S. Chang, L. Mao, and F. R. Khuri
Lack of Interleukin-10 Expression Could Predict Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
Clin. Cancer Res., May 1, 2003; 9(5): 1785 - 1791.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. X. Zhu, S. Sharma, B. Gardner, B. Escuadro, K. Atianzar, D. P. Tashkin, and S. M. Dubinett
IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity
J. Immunol., April 1, 2003; 170(7): 3585 - 3591.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Miura, C. J. Thoburn, E. C. Bright, W. Chen, S. Nakao, and A. D. Hess
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD
Blood, September 18, 2002; 100(7): 2650 - 2658.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
I Y Rosenblum and A D Dayan
Carcinogenicity testing of IL-10: principles and practicalities
Human and Experimental Toxicology, July 1, 2002; 21(7): 347 - 358.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
S. Sharma, M. Stolina, L. Zhu, Y. Lin, R. Batra, M. Huang, R. Strieter, and S. M. Dubinett
Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma
Cancer Res., September 1, 2001; 61(17): 6406 - 6412.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. M. Koelle, S. N. Reymond, H. Chen, W. W. Kwok, C. McClurkan, T. Gyaltsong, E. W. Petersdorf, W. Rotkis, A. R. Talley, and D. A. Harrison
Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans
J. Virol., December 1, 2000; 74(23): 10930 - 10938.
[Abstract] [Full Text]

Home page
 BloodHome page
L. Cervenak, L. Morbidelli, D. Donati, S. Donnini, T. Kambayashi, J. L. Wilson, H. Axelson, E. Castanos-Velez, H.-G. Ljunggren, R. D. W. Malefyt, et al.
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
Blood, October 1, 2000; 96(7): 2568 - 2573.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. X. Zhu, S. Sharma, M. Stolina, B. Gardner, M. D. Roth, D. P. Tashkin, and S. M. Dubinett
{Delta}-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
J. Immunol., July 1, 2000; 165(1): 373 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sharma, M. Stolina, J. Luo, R. M. Strieter, M. Burdick, L. X. Zhu, R. K. Batra, and S. M. Dubinett
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
J. Immunol., May 1, 2000; 164(9): 4558 - 4563.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Stolina, S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al.
Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis
J. Immunol., January 1, 2000; 164(1): 361 - 370.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sharma, M. Stolina, Y. Lin, B. Gardner, P. W. Miller, M. Kronenberg, and S. M. Dubinett
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
J. Immunol., November 1, 1999; 163(9): 5020 - 5028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Dobrzanski, J. B. Reome, and R. W. Dutton
Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases
J. Immunol., June 1, 1999; 162(11): 6671 - 6680.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Rohrer, A. L. Barsoum, D. L. Dyess, J. A. Tucker, and J. H. Coggin Jr.
Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes
J. Immunol., June 1, 1999; 162(11): 6880 - 6892.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. Stremmel, E.A. Greenfield, E. Howard, G.J. Freeman, and V.K. Kuchroo
B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4-dependent Mechanism
J. Exp. Med., March 15, 1999; 189(6): 919 - 930.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Steinbrink, H. Jonuleit, G. Muller, G. Schuler, J. Knop, and A. H. Enk
Interleukin-10-Treated Human Dendritic Cells Induce a Melanoma-Antigen-Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells
Blood, March 1, 1999; 93(5): 1634 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. K. Halak, H. C. Maguire Jr., and E. C. Lattime
Tumor-induced Interleukin-10 Inhibits Type 1 Immune Responses Directed at a Tumor Antigen As Well As a Non-Tumor Antigen Present at the Tumor Site
Cancer Res., February 1, 1999; 59(4): 911 - 917.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Groux, M. Bigler, J. E. de Vries, and M.-G. Roncarolo
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
J. Immunol., April 1, 1998; 160(7): 3188 - 3193.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Hagenbaugh, S. Sharma, S. M. Dubinett, S. H.-Y. Wei, R. Aranda, H. Cheroutre, D. J. Fowell, S. Binder, B. Tsao, R. M. Locksley, et al.
Altered Immune Responses in Interleukin 10 Transgenic Mice
J. Exp. Med., June 16, 1997; 185(12): 2101 - 2110.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.